Tinabinol

Tinabinol (INN: SP-119) is a synthetic cannabinoid drug that is a sulfur based analogue of dimethylheptylpyran which was patented as an antihypertensive but was never marketed.^[1][2]

Tinabinol
INN: SP-119

Clinical data
Drug class	Cannabinoid
ATC code	None
Identifiers
IUPAC name 5,5-dimethyl-8-(3-methyl-2-octanyl)-1,2,3,5-tetrahydrothiopyrano[2,3-c]chromen-10-ol
CAS Number	50708-95-7
PubChem CID	65443
ChemSpider	58905
UNII	455Y914AKK
CompTox Dashboard (EPA)	DTXSID20866160
Chemical and physical data
Formula	C23H34O2S
Molar mass	374.58 g·mol−1
3D model (JSmol)	Interactive image
SMILES O3c1cc(cc(O)c1\C2=C(\SCCC2)C3(C)C)C(C)C(C)CCCCC
InChI InChI=1S/C23H34O2S/c1-6-7-8-10-15(2)16(3)17-13-19(24)21-18-11-9-12-26-22(18)23(4,5)25-20(21)14-17/h13-16,24H,6-12H2,1-5H3 Key:YCNTYPIGYVTFBO-UHFFFAOYSA-N

See also

• Dimethylheptylpyran
• Dronabinol
• Tetrahydrocannabinol
• Nabitan